Fang Xu

1PUBLICATIONS
0CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Mar 21, 2022
Pembrolizumab: A reliable second-line treatment option for advanced esophageal cancer.

Li Zheng, Yabi Zhu, Yangyang Liu

Pageof 1

Frequent Collaborators